Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor α or the peroxisome proliferator nafenopin

被引:37
作者
Chevalier, S
Macdonald, N
Tonge, R
Rayner, S
Rowlinson, R
Shaw, J
Young, J
Davison, M
Roberts, RA
机构
[1] AstraZeneca Pharmaceut, Zeneca Cent Toxicol Lab, Canc Biol Grp, Macclesfield SK10 4TJ, Cheshire, England
[2] AstraZeneca Pharmaceut, Proteom Grp EST Biol, Macclesfield SK10 4TJ, Cheshire, England
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 15期
关键词
peroxisome proliferator; proteome; hepatocyte; epidermal growth factor; tumour necrosis factor alpha;
D O I
10.1046/j.1432-1327.2000.01487.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferators are nongenotoxic rodent-liver carcinogens that have been shown to cause both an induction of hepatocyte proliferation and a suppression of apoptosis. Both epidermal growth factor (EGF) and the peroxisome proliferator nafenopin induce DNA replication in primary rat hepatocyte cultures, but apparently through different signalling pathways. However, both EGF and nafenopin require tumour necrosis factor alpha (TNF alpha) signalling to induce DNA replication. By examining proteins isolated from rat primary hepatocyte cultures using two-dimensional gel electrophoresis and mass spectrometry, we found that proteins showing an altered expression pattern in response to nafenopin differed from those showing altered expression in response to EGF. However, many proteins showing altered expression upon stimulation with TNF alpha were common to both the EGF and nafenopin responses. These proteome profiling experiments contribute to a better understanding of the molecular mechanisms involved in the response to peroxisome proliferators. We found 32 proteins with altered expression upon stimulation with nafenopin, including muscarinic acetylcholine receptor 3, intermediate filament vimentin and the beta subunit of the ATP synthase. These nonperoxisomal protein targets offer insights into the mechanisms of peroxisome proliferator-induced carcinogenesis in rodents and provide opportunities to identify toxicological markers to facilitate early identification of nongenotoxic carcinogens.
引用
收藏
页码:4624 / 4634
页数:11
相关论文
共 45 条
  • [1] The effects of peroxisome proliferators on protein abundances in mouse liver
    Anderson, NL
    EsquerBlasco, R
    Richardson, F
    Foxworthy, P
    Eacho, P
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 137 (01) : 75 - 89
  • [2] INDUCTION OF ADIPOSE CONVERSION IN 3T3-L1 CELLS IS ASSOCIATED WITH AN EARLY PHOSPHORYLATION OF A PROTEIN PARTLY HOMOLOGOUS WITH MOUSE VIMENTIN
    BRANDES, R
    ARAD, R
    GAATHON, A
    BARTANA, J
    [J]. FEBS LETTERS, 1993, 333 (1-2) : 179 - 182
  • [3] 2D protein electrophoresis: can it be perfected?
    Celis, JE
    Gromov, P
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (01) : 16 - 21
  • [4] G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin
    Chevalier, S
    Roberts, RA
    [J]. CARCINOGENESIS, 1999, 20 (07) : 1209 - 1213
  • [5] Chevalier S, 1999, J CELL SCI, V112, P4785
  • [6] Chevalier S, 1998, ONCOL REP, V5, P1319
  • [7] Peroxisome proliferator-activated receptors: Nuclear control of metabolism
    Desvergne, B
    Wahli, W
    [J]. ENDOCRINE REVIEWS, 1999, 20 (05) : 649 - 688
  • [8] Edvardsson U, 1999, J LIPID RES, V40, P1177
  • [9] Edvardsson U, 1999, ELECTROPHORESIS, V20, P935, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<935::AID-ELPS935>3.0.CO
  • [10] 2-6